(63 days)
The Mennen Medical VitaLogik BIS interface is intended for use under the direct supervision of a licensed healthcare practitioner or by personnel trained in its proper use. It is intended for use on adult and pediatric patients within a hospital or medical facility providing patient care to monitor the state of the brain by data acquisition of EBG signals.
The BIS Index, a processed parameter may be used as an aid in monitoring the effects of certain anesthetic agents. Use of BIS monitoring to help guide anesthetic administration may be associated with the reduction of the incidence of awareness with recall in adults during general anesthesia and sedation.
The Bispectral Index is a complex technology, intended for use only as an adjunct to clinical judgment and training.
In addition, the clinical utility, risk/benefit, and application of this device have not undergone full evaluation in the pediatric population.
The Intended Use of the VitaLogik monitor as indicated above are same as the Indications For Use.
The VitaLogik is a multiparameter physiological patient monitor, capable of monitoring:
- ECG/Heart Rate
- Invasive blood pressure
- Non-invasive blood pressure
- Respiration
- Pulse oximetry
- Two temperature channels
- Cardiac output
- EtCo2
- Spirometry
- BBG
- BIS Interface (new subject of this application)
Main components of the VitaLogik: The VitaLogik system consists of:
(A) a Bed side computer with
(B) Display
(A) The Bed side computer acquires, processes, and converts vital signs from the patient into waveforms and digital signals.
The VitaLogik can acquire the following physiological signals of the patient:
- ECG Waveform and measures Heart Rate, ST and Arrhythmia
- Blood Pressures Waveform and measures Systole, Diastole and Mean Pressure
- Temperature As a numeric value in C or F
- SpO2 Photoplethysmographic waveform and numeric value of the oxygen saturation and pulse rate
- NIBP Systolic, Diastolic and Mean pressure with measuring time stamp
- EtCO2 EtCO2, inCO2 and Respiration Rate
- BIS Index of conciseness and EEG waveform
(B) The Display is used to display the measurement and waveforms, and alarms. With touch screen option it provides also the control functions, replacing the use of hardware keys. Information from each vital sign is presented in a separate portion of the display. Each vital sign is labeled for identification and numeric value. Displayed Vital sign information can include: Primary Vital Sign Name, waveform, Vital Sign Numeric Value, Alarm Status Message.
Operation of the VitaLogik is accomplished by interaction with front panel controls. A quickknob control allows direct interaction with displayed menus for direct parameter selection and setup. Where manual entry of alphanumeric information is required, a menu keyboard menu is displayed.
The VitaLogik is a reusable, software driven, patient monitor, intended for use as part of a physiological monitoring system in a hospital environment. As such it is not a life supporting, nor life sustaining device; nor is it implantable and therefore sterility is not a consideration.
The VitaLogik monitors the patient's vital sign data derived by the VitaLogik are presented on the monitor as waveform and numeric displays. The VitaLogik acquire vital signs data from the patient, and display their waveforms and alarms indications on the VitaLogik display.
The VitaLogik is not a kit and does not contain any drug or biological products. The BIS Interface of the VitaLogik patient monitor is not sold as a stand alone device, but as part of a multiparameter physiological patient monitoring system (VitaLogik).
In chapter 1, page 1-2 of the VitaLogik Operating Manual, the following Prescription Notice appears: "Federal United States law restricts the sale and use of this instrument to qualified medical personnel only"
Functional description of the new VitaLogik BIS Interface:
(Interface to Aspect BISx device cleared in K 040183)
The BIS Interface is used to monitor dual channel EBG waveform and the BIS index, used to estimate the level of conciseness of patient under anesthesia, or patients in the ICU that may be with limited conciseness.
The BIS index together with several quality parameters are displayed and stored by the VitaLogik monitor.
Here's an analysis of the provided text regarding the VitaLogik Patient Monitor with BIS Interface, structured according to your requested information:
1. Table of Acceptance Criteria and Reported Device Performance
The provided text describes a 510(k) submission for a device modification, specifically the addition of a BIS Interface to the existing VitaLogik Patient Monitor. The primary goal of this submission is to demonstrate substantial equivalence to a predicate device (Envoy BIS Module). Therefore, the "acceptance criteria" are predominantly framed around matching the specifications and performance of the predicate device, rather than explicit numerical thresholds for clinical outcomes.
| Acceptance Criterion (Implicit) | Reported Device Performance (VitaLogik BIS Interface) |
|---|---|
| Functional Equivalence: Display and monitor same parameters as predicate. | Same: Monitors BIS numeric, two EEG, EMG vertical bar (x2), SR, BC numeric. Provides trend of BIS and EMG. Displays EEG waveform. |
| Data Display: Identical representations (numeric values, waveforms, trends). | Same: Waveform + Trend (EEG waveform and BIS + EMG graphic trend). BIS Task window (BIS, EEG waveform, EMG, SQI, SR, BC, Alarm limits, Alarm messages). Continuous graphic trend of BIS index and quality parameters available. Real-time EEG signal continuously displayed. |
| Wave Scale & Sweep Speed: Matching technical display parameters. | Same: Wave scale (5, 10, 25, 50, 100 µV/cm). EEG sweep speed (6.25, 12.5, 25 mm/sec). Sweep speed for Input (15, 30, 50 mm/second). |
| Data Storage Capacity: Sufficient storage for relevant parameters. | VL 5x00: Same as predicate (45 days EEG, 3 months BIS, SEF, EMG, SQI, SR, BC). VL 4x00: 6 days (BIS, SEF, EMG, SQI, SR, BC). (Note: This is a difference, but determined not to raise new safety/effectiveness issues) |
| Electrode Impedance Testing: Automatic and manual testing capabilities. | Same: Auto on connection of sensor and Manual anytime. |
| Patient Compatibility: Adult and pediatric populations. | Same: Adult and Pediatric. |
| Input Specifications: Matching parameters set by the BISx unit. | Same: Set by BISx (EEG Input signal, EEG Bandwidth, EMG bandwidth, DC offset, Input Impedance, Input Capacitance, Common Mode rejection, Input Noise). |
| Number of Channels: Two channels. | Same: Two. |
| Smoothing Rate: Matching processing parameter. | Same: 10, 15, or 30 seconds. |
| Electrical Specifications: Compliance with electrical safety and performance parameters. | Same: Patient leakage current (< 100 µV), Isolation (4000VAC), Operating Voltage (+5 VDC, +/- 12 VDC), Power consumption (4.5 Watt maximum). Complies with MDD Class IIb, EN 60601-1, Externally powered, rated for continuous operation. Aspect BISx pod is Type BF, defibrillator proof, Body floating applied part. |
| Alarms: Audible alarms for High and Low BIS, and Caution alarms. | Same: Audible for High and Low BIS, Caution alarm. |
| Environmental Requirements: Operating and storage temperatures, humidity, and altitude. | Same: Storage (Temp: -15° to 60° C, Humidity: 10 to 95% non-condensing, Altitude: -350 to 5,000m). Operating (Temp: +5° to 40° C, Humidity: 10 to 95% non-condensing, Altitude: -350 to 3,050 m). |
| Compliance with Industry Standards: Adherence to relevant safety and performance standards (e.g., IEC 60601 series, AAMI/ANSI). | Complies with numerous standards: IEC 60601-1, -1-1, -1-2, -1-4, -1-6, -1-8, -2-27, -2-30, -2-34, -2-49. AAMI/ANSI ES1, EC13. |
| Safety and Effectiveness: No new issues of safety and effectiveness compared to the predicate. | Conclusion: "Any differences between the two monitors in the method of BISx connection does not raise any new issues of safety and effectiveness. The Intended use of the Mennen Medical VitaLogik BIS interface and the predicated device is the same." This is the ultimate "performance" reported for substantial equivalence. |
| Performance Testing: Ensures acquisition and display are equivalent to predicate. | Reported: "extensive performance testing to ensure that the acquisition and display of the patient data and waveforms by the VitaLogik with BIS interface are equivalent to the predicate device Envoy with BIS module." SW Validation comparing performance. Final testing for functional requirements and performance specifications. Electrical Safety and EMC testing by an independent lab (SII). Performance also tested by Aspect Medical. |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: The document does not specify a numerical sample size for patients or data used in the performance testing. It refers to "extensive performance testing," "SW Validation," and "Final testing." These are likely internal verification and validation activities rather than a formal clinical study with a defined sample size for statistical inference on patient data.
- Data Provenance: Not specified. Given the nature of a 510(k) for a device modification, the testing likely involved simulated data, test bench measurements, and possibly limited internal clinical evaluations for verification, rather than large-scale prospective clinical trials. The statement that "The performance of the BIS interface was also tested by Aspect Medical as per the attached certificate (part 21)" suggests some level of external validation, but details of that testing are not provided in this document.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
This information is not provided in the document. The study described focuses on demonstrating technical and functional equivalence to a predicate device, rather than establishing a new clinical ground truth. For a device like a patient monitor, the "ground truth" for the displayed physiological parameters is typically the actual physical measurement itself (e.g., EEG signals, blood pressure, temperature), and the device's accuracy is verified against calibrated instruments or the predicate's output.
4. Adjudication Method for the Test Set
This information is not provided and is generally not applicable to the type of technical equivalence testing described here. Adjudication by experts is typically for subjective assessments or outcomes in clinical studies, which is not the focus of this 510(k) submission.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and the Effect Size
No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not conducted or described. This type of study assesses how human readers perform with and without AI assistance, which is not relevant for a device modification involving only an interface to display existing physiological parameters like the BIS Index. The device itself is not an "AI" in the sense of providing diagnostic or interpretive assistance beyond presenting raw and processed physiological data.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
Yes, a form of standalone testing was done. The VitaLogik BIS Interface itself is essentially an algorithm/hardware combination that:
- Receives data from the Aspect BISx unit.
- Transfers it to the VitaLogik bedside computer.
- Displays and stores the BIS parameter and quality parameters.
The "SW Validation of the performance of the VitaLogik with BIS interface as compared to the Envoy BIS module" and "Final testing for the VitaLogik BIS Interface included performance tests designed to ensure that the device meets all functional requirements and performance specifications" describe tests of the device's ability to accurately process, display, and store the parameters from the BISx, independent of a specific human-in-the-loop clinical outcome study. The comparison to the predicate device is a form of standalone performance assessment against an established benchmark.
7. The Type of Ground Truth Used
The "ground truth" in this context is implicitly the output of the Aspect BISx unit and the performance of the predicate Envoy BIS module. The VitaLogik BIS Interface is designed to accurately receive, display, and store the already processed BIS Index and related parameters as calculated by the BISx. The core ground truth for the measurements themselves originates from the BISx's processing of EEG signals. For the interface's performance, the ground truth is whether it accurately reflects what the BISx unit is sending and whether its display/storage matches the established predicate device's capabilities.
8. The Sample Size for the Training Set
This information is not applicable and not provided. The VitaLogik BIS Interface is not an AI/ML algorithm that is "trained" on a dataset in the conventional sense. It is a hardware/software interface designed to relay and display data from another cleared device (BISx). Its development involves software engineering and testing against specifications, not machine learning model training.
9. How the Ground Truth for the Training Set Was Established
This information is not applicable and not provided, as there is no "training set" for this device modification.
{0}------------------------------------------------
Food and Drug Administration
Device Modification - VitaLogik Patient Monitor
510(k) for addition of BIS Interface
DEC 1 6 2008
Name: Registration Number: Operator Number: Address: Postal Address:
Mennen Medical Ltd. 9611022 9069173 4 Hayarden Street, Yavne, 81228, Israel PO Box 102, Rehovot, 76100, Israel
Tel: Fax: Contact person: +972-8-9323333 +972-8-9328510
Ifat Oren, Regulatory Affairs
Traditional 510(k): Device Modification - VitaLogik Patient Monitor - BIS
Terminology
VitaLogik = Subject of this 510(k). The VitaLogik Patient Monitor is a modified device, a system identical to the VitaLogik Patient Monitor with the addition of BISx Interface. The VitaLogik 5X00 was clearded by the FDA on 20th Dec, 2005 K052288 The VitaLogik 4X00 was cleared by the FDA on 21th Nov, 2007 K073140
BIS module of the Envoy monitor- The predicate device. The addition of the BIS Module to the Envoy Patient Monitor was cleared by the FDA at Oct. 2007 K071899
Intended Use of the VitaLogik Patient Monitor
The VitaLogik Monitor is a physiological patient monitor intended to be used for monitoring vital signs of critically ill adult and pediative patients in the hospital environment, such as: ECG/Heart Rate, Invasive Blood Pressure, Respiration, Temperature, Noninvasive Blood Pressure, CO, Pulse Oximetry, EtCO2 and BIS. The VitaLogik may be used to monitor a wide range of patient conditions in many different clinical specialties within the hospital. The device is intended for use by qualified health care providers. who will determine when use of the device is indicated, based upon their professional assessment of the patient's medical condition.
Page 1 of 12
{1}------------------------------------------------
Indications for use - VitaLogik with BIS Interface
VitaLogik series is intended for use as a multiparameter physiological patient monitoring system. The VitaLogik series can monitor ECG/heart rate, invasive blood pressure channels, temperature channels, pulse oximetry, respiration, non-invasive blood pressure and EtCO2. This effectively allows the VitaLogik series to monitor a wide-range of adult, pediatric and neonatal patient conditions, in many different areas of the hospital.
Functions include display of multiparameter waveforms, vital signs, alarm & status messages. The Mennen Medical VitaLogik is intended for sale as a system for monitoring and recording patient information or any in-hospital application requiring patient monitoring.
The following are examples of intended clinical applications:
-
- Critical Care Patients
-
- Cardiac Step-down/Telemetry Units
-
- Emergency Departments
-
- Intra-operative (Anesthesia) Monitoring
-
- Post Anesthesia Care
BIS - Indication for use
The Mennen Medical VitaLogik BIS interface
is intended for use under the direct supervision of a licensed healthcare practitioner or by personnel trained in its proper use. It is intended for use on adult and pediatic patients within a hospital or medical facility providing patient care to monitor the state of the brain by data acquisition of EBG signals.
The BIS Index, a processed parameter may be used as an aid in monitoring the effects of certain anesthetic agents. Use of BIS monitoring to help guide anesthetic administration may be associated with the reduction of the incidence of awareness with recall in adults during general anesthesia and sedation.
- The Bispectral Index is a complex technology, intended for use only as an adjunct to clinical judgment and training.
- & In addition, the clinical utility, risk/benefit, and application of this device have not undergone full evaluation in the pediatric population.
*The Intended Use of the VitaLogik monitor as indicated above are same as the Indications For Use.
{2}------------------------------------------------
Device Description - VitaLogik Patient Monitor with BIS Interface
The VitaLogik is a multiparameter physiological patient monitor, capable of monitoring:
- ECG/Heart Rate .
- . Invasive blood pressure
- Non-invasive blood pressure .
- Respiration �
- Pulse oximetry .
- Two temperature channels �
- Cardiac output
- . EtCo2
- Spirometry .
- BBG ●
- BIS Interface (new subject of this application) ●
Main components of the VitaLogik: The VitaLogik system consists of:
(A) a Bed side computer with
(B) Display
(A) The Bed side computer acquires, processes, and converts vital signs from the patient into waveforms and digital signals.
The VitaLogik can acquire the following physiological signals of the patient:
- · ECG Waveform and measures Heart Rate, ST and Arrhythmia
- · Blood Pressures Waveform and measures Systole, Diastole and Mean Pressure
- · Temperature As a numeric value in C or F
- · SpO2 Photoplethysmographic waveform and numeric value of the oxygen saturation and pulse rate
- · NIBP Systolic, Diastolic and Mean pressure with measuring time stamp
- · EtCO2 EtCO2, inCO2 and Respiration Rate
- · BIS Index of conciseness and EEG waveform
{3}------------------------------------------------
(B) The Display is used to display the measurement and waveforms, and alarms. With touch
screen option it provides also the control functions, replacing the use of hardware keys. Information from each vital sign is presented in a separate portion of the display. Each vital sign is labeled for identification and numeric value. Displayed Vital sign information can include: Primary Vital Sign Name, waveform, Vital Sign Numeric Value, Alarm Status Message.
Operation of the VitaLogik is accomplished by interaction with front panel controls . A quickknob control allows direct interaction with displayed menus for direct parameter selection and setup. Where manual entry of alphanumeric information is required, a menu keyboard menu is displayed.
The VitaLogik is a reusable, software driven, patient monitor, intended for use as part of a physiological monitoring system in a hospital environment. As such it is not a life supporting, nor life sustaining device; nor is it implantable and therefore sterility is not a consideration.
The VitaLogik monitors the patient's vital sign data derived by the VitaLogik are presented on the monitor as waveform and numeric displays. The VitaLogik acquire vital signs data from the patient, and display their waveforms and alarms indications on the VitaLogik display.
The VitaLogik is not a kit and does not contain any drug or biological products. The BIS Interface of the VitaLogik patient monitor is not sold as a stand alone device, but as part of a multiparameter physiological patient monitoring system (VitaLogik).
In chapter 1, page 1-2 of the VitaLogik Operating Manual, the following Prescription Notice appears: "Federal United States law restricts the sale and use of this instrument to qualified medical personnel only"
Functional description of the new VitaLogik BIS Interface:
(Interface to Aspect BISx device cleared in K 040183)
The BIS Interface is used to monitor dual channel EBG waveform and the BIS index, used to estimate the level of conciseness of patient under anesthesia, or patients in the ICU that may be with limited conciseness.
The BIS index together with several quality parameters are displayed and stored by the VitaLogik monitor.
{4}------------------------------------------------
The parameters displayed and stored by the VitaLogik monitor are the following:
| Parameter | Range | Description |
|---|---|---|
| BIS | 0 - 99 | Bispectral Index: The measure of consciousness of apatient, (0 = no brain activity), (100 = fully conscious). |
| EMG | 30 - 55 dB | Electromyography: The absolute power of muscleactivity and artifacts in the 70 - 110 Hz range. Value is indB with respect to 0.0001 μV2. |
| SQI | 0 - 100 % | Signal Quality Index: The percentage of good epochsand suppressed epochs in the last 120 epochs collectedthat could be used in the Bispectral Index calculation. |
| SR | 0-100 % | Suppression Ratio: The percentage of epochs in thepast 63 seconds in which the EEG signal is consideredsuppressed. |
| BC | 0-30 | Burst Count: The number of EEG bursts in the lastminute. An EEG burst is a momentary period of EEGactivity among isoelectric or flat EEG. Blanked if SR isless than 5. Activated by connection of an Extend sensor. |
| SEF | 0.5 - 30 Hz | Spectral Edge Frequency: The frequency at which 95%of the total power lies below it and 5% lies above it. |
To get these parameters we use Aspect sensor and BISx unit attached to the VitaLogik with an interface cable produced by Aspect.
The BISx is a product of Aspect and Is sold to Mennen Medical under OEM agreement.
The BIS sensors, that consist of a set of 4 electrodes, attached to the patients forehead, are Aspect products and will be sold to end users by Aspect directly and not by Mennen Medical.
The function of the VitaLogik BIS Interface and VitaLogik display and storage capabilities is to display the BIS parameter and the quality parameters. To provide alarm limits for the BIS index and provide visual and audible alarms in case of the BIS index being out of the preset range, or in cases that the quality parameters are in such range that they limit the reliability of the BIS index.
The decision on artifacts and limited rellability are provided to the VitaLogik by the BISx Interface. Those can not be set by Mennen Medical VitaLogik monitor. The clinical BIS alarm limits are set by the user, on the VitaLogik monitor.
The Description of the BIS measurement system is described below:
- The BIS sensor (Made and sold by Aspect) is attached to the patients forehead. (See attached 1.
- BISx (Figure 1 OEM by Aspect) is receiving, amplifying and digitizing the EEG brain signals. It 2. analyses the EEG and creates the BIS index and the quality parameters and sends them to the BIS module by RS232 protocol
- VitaLogik BIS interface receives the BISx output and transfers it to the VitaLogik bedside 3. computer for display and storage.
- BIS Display and storage: BIS is displayed as a number. EMG and SQI are displayed as vertical 4. bars, and SR and BC as numbers in the BIS display area.
- ട്. Clinical and technical alarm messages are displayed in the BIS display area.
Page 5 of 12
{5}------------------------------------------------
- Continuous graphic trend of the BIS index and quality parameters are also available on the screen 6. under the label CRG.
-
- The real time EEG signal is continuously displayed on the monitor screen.
- In edition, the VitaLogik provides long term storage and display of the BIS index and its related 8. parameters as numeric Charts and graphic Trends.
Image /page/5/Picture/4 description: The image shows a black and gray device with two cords attached to it. The device is round and has a gray center with the letters "als2" written on it. The cords are coiled and appear to be made of a flexible material.
Figure 1: BISx™ device
Substantial Equivalence Discussion
Comparison between the BIS Interface to the VitaLogik with the predicated device- BIS Module to the Envoy
Specification Comparison
| Envoy BIS Module | VitaLogik BIS Interface | |
|---|---|---|
| Part Number | 551-147-000 | VL 5X00- 640-000-000/640-OPT-080/2VL 4X00- 681-000-000/681-OPT-080/2 |
| 510K | K071899 | Subject of this application |
| Features | ||
| Monitoring profile | BIS numeric + Two EEG +EMG vertical bar + EMGvertical bar + SR, BC numeric +Trend of BIS and EMG | Same |
| Waveform + Trend | EEG waveform and BIS + EMGgraphic trend | Same |
| Wave scale | 5, 10, 25, 50, 100 µV/cm | Same |
Page 6 of 12
{6}------------------------------------------------
Food and Drug Administration
Device Modification – VitaLogik Patient Monitor
510(k) for addition of BIS Interface
| EEG sweep speed | 6.25, 12.5, 25 mm/sec | Same | |
|---|---|---|---|
| BIS Task window | BIS, EEG waveform, EMG, SQI,SR, BC,Alarm limits,Alarm messages | Same | |
| Data Storage | EEG waveform – 45 days3 month of:BIS,Spectral Edge Frequency (SEF),Electromyography strength(EMG)Signal Quality Index (SQI)Suppression Ratio (SR)Burst Count (BC) | VL 5x00 | VL 4x00 |
| Same | 6 days | ||
| Same | 10 days | ||
| ElectrodeImpedance testing | Auto on connection of sensorand Manual any time | Same | |
| Patientcompatibility | Adult and Pediatric | Same | |
| Input Specification | Set By BISx | Set By BISx | |
| Number of channels | Two | Same | |
| Sweep speed | 15, 30, 50 mm/second | Same | |
| EEG Input signal | +/- 1µV to +/-400 μV | Same | |
| EEG Bandwidth | 0.25 to 100 Hz | Same | |
| EMG bandwidth | 70 to 110 Hz | Same | |
| DC offset | +/- 300 mV | Same | |
| Input Impedance | >50 MΩ | Same | |
| Input Capacitance | <100 pF | Same | |
| Common Moderejection | > 110dB | Same | |
| Input Noise | <0.3 µV RMS (2.0µV peak topeak to peak) | Same | |
| Smoothing rate | 10, 15, or 30 seconds | Same | |
| ElectricalSpecification | |||
| Patient leakagecurrant | < 100 μV | Same | |
| Isolation | 4000VAC | Same | |
| Operating Voltage | +5 VDC, +/- 12 VDC | Same | |
| Power consumption | 4.5 Watt maximum | Same | |
| Alarms | Audible for High and Low BIS | Same | |
| Caution alarm | Same | ||
| Classification | MDD Class IIb | Same | |
| EN 60601-1 | |||
| Externally powered, rated forcontinuous operation | |||
| Aspect BISx pod | Type BF, defibrillator proof,Body floating applied part | Same | |
| EnvironmentalRequirement | |||
| Storage | Temperature: -15° to 60° C | Same | |
| Humidity : 10 to 95% (non-condensing) | |||
| Altitude: -350 to 5,000m | |||
| Operating | Temperature: +5° to 40° C | Same | |
| Humidity : 10 to 95% (non-condensing) | |||
| Altitude: -350 to 3,050 m |
Page 7 of 12
{7}------------------------------------------------
Food and Drug Administration Device Modification - VitaLogik Patient Monitor
510(k) for addition of BIS Interface
Page 8 of 12
{8}------------------------------------------------
VitaLogik BIS Interface and Envoy BIS module: Similarities and Differences:
Similarities:
The following technological and other characteristic/features apply to both Envoy BIS module and VitaLogik BISx interface:
- Both use Aspect Medical Systems BISx pod as their input device ●
- Both provide the BISx pod its power (5 Volt) .
- Both receive from the BISx by serial data communication the EEG waveform and the BIS ● parameter together with its quality and related parameters.
- Both have the capability to display BEG waveform and BIS numeric parameters ●
- Both enable correlation between BIS and other vital signs displayed and stored by the . monitor to which the BIS module is inserted.
Differences:
The difference between the VitaLogik BIS interface and the Envoy BIS Module are limited to the method of connection of the BISx to the monitor.
- . The Envoy has a BIS module to which the BISx is connected
- The VitaLogik has a universal connector (UIM) to which the BISx is connected t
Conclusion of comparison
We consider the VitaLogik BIS interface to be substantially equivalent to the Envoy BIS module
Any differences between to two monitors in the method of BISx connection does not raise any new issues of safety and effectiveness.
The Intended use of the Mennen Medical VitaLogik BIS interface and the predicated device is the same.
Verification, Validation and Testing
The VitaLogik BIS Interface has been subject to extensive performance testing to ensure that the acquisition and display of the patient data and waveforms by the VitaLogik with BIS interface are equivalent to the predicate device Envoy with BIS module.
At the system level, SW Validation of the performance of the VitaLogik with BIS interface as compared to the Envoy BIS module, was carried out in accordance with the test plan described in the Mennen Medical Validation Test Procedure for the VitaLogik BIS module.
The SW Test Description for the VitaLogik with BIS interface was derived from the SW Test Description for the VitaLogik, with the necessary addition of the BIS measurements
Final testing for the VitaLogik BIS Interface included performance tests designed to ensure that the device meets all functional requirements and performance specifications, in accordance with the requirements of the Final Test Procedure for the VitaLogik BIS Interface. Electrical Safety testing and EMC testing were performed by an independent testing laboratory (Standard Institute of Israel SII) to ensure that the device complies to applicable industry and safety standards.
Page 9 of 12
{9}------------------------------------------------
Food and Drug Administration Device Modification - VitaLogik Patient Monitor 510(k) for addition of BIS Interface
The performance of the BIS interface was also tested by Aspect Medical as per the attached certificate (part 21)
Proposed Labeling
The system will be called VitaLogik with BIS Interface
Part numbers
| Monitor | Monitor p/n | BIS kit p/n |
|---|---|---|
| VitaLogik 5x00 | 640-000-000 | 640-OPT 080/2 |
| VitaLogik 4x00 | 681-000-000 | 681-OPT 080/2 |
Page 1-2 of the introduction to the VitaLogik User Guide contains the following Prescription Notice: 'Federal United States law restricts the sale and use of this instrument to qualified medical personnel only."
The following symbols appear on page 2-4 of the VitaLogik User's Guides under the section entitled "Label Symbols".
Page 10 of 12
{10}------------------------------------------------
| Symbol | Description | Location of Symbol |
|---|---|---|
| ~ | Alternating Current | Alternating Current rear of theProcessing unit, IsolationTransformer. |
| Equipotential | On the rear of the Processingunit | |
| Attention, consult accompanyingdocuments (Service to beperformedby qualified technician, consultservicemanual before removing cover) | On Isolation Transformer andProcessing unit. | |
| Off (power disconnection frommain power supply) | On right of Processing unit | |
| On (power connection to the mainpower supply) | On the right of the Processingunit. | |
| Type BF applied partdefibrillator-proof | On NIBP and Sp02 | |
| Type CF applied part - directcardiacapplicationdefibrillator-proof | On ECG, and Dual BP andCO/2 TMP | |
| --- | Fuse | On rear of Processing unit andIsolation Transformer |
labels
Image /page/10/Picture/3 description: The image shows four labels from Mennen Medical Ltd. The labels contain information such as the model name (VitaLogik4000, VitaLogik4500, VITALOGIK 5000, VITALOGIK 5500), part number, serial number, address (4 Ha-Yarden Street, Yavne, P.O.B. 102, Rehovot 76100, Israel), and the manufacturing date (OCT 2007, AUGUST 2008). Each label also includes a CE marking and the number 0473.
Page 11 of 12
{11}------------------------------------------------
Voluntary Standards
The VitaLogik complies with (amongst others) the following voluntary standards:
-
- IEC 60601-1: (2005) Medical Electrical Equipment Part:1 General Requirements for Safety
-
- IEC 60601-1-1 (2000) Medical Electrical Equipment Part 1-1 : General Requirements for Safety Collateral Standard: Safety Requirements for Medical Electrical Systems
-
- IEC 60601-1-2 (2007): Medical Electrical Equipment Part 1-2: General Requirements for Safety - Collateral Standard: Electromagnetic Compatibility - Requirements and Tests.
- & IEC 60601-1-4 (2000):
Medical electrical equipment - Part 1-4: General requirements for safety - Collateral Standard: Programmable electrical medical systems
-
- IEC 60601-1-6 (2006):
Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance - Collateral standard: Usability
- IEC 60601-1-6 (2006):
-
- IEC 60601-1-8 (2006): General requirements for safety-collateral requirements, test & guidance alarm system in medical electrical equipment & medical electrical systems
for
- IEC 60601-1-8 (2006): General requirements for safety-collateral requirements, test & guidance alarm system in medical electrical equipment & medical electrical systems
-
- IEC 60601-2-27 (2005): Medical electrical equipment. Part 2, Requirements for salety of electrocardiograph monitoring equipment.
-
- IEC 60601-2-30 (1999): Medical electrical equipment, Part 2 - requirements for safety of automatic cycling indirect blood pressure monitoring equipment
-
- IEC 60601-2-34 (2005): Medical electrical equipment. Part 2 - Particular requirements for the safety of direct blood pressure monitoring equipment
-
- IEC 60601-2-49 (2006): Particular Requirements for the safety of multifunction patient monitoring equipment
-
AAMI/ANSI ES1: Safe Current Limits for Electromedical Apparatus, and .
-
AAMI/ANSI EC13: Cardiac Monitors, Heart Rate Meters and Alarms. .
{12}------------------------------------------------
Image /page/12/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. In the center of the seal is an abstract image of an eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Mennen Medical Ltd c/o Mr. Ifat Oren OA and Regulatory Affairs P.O. Box 102 Rehovot, Israel 76100
APR - 9 2012
Re: K083063
Trade/Device Name: BIS Interface for VitaLogik Patient monitors Regulation Number: 21 CFR 882.1400 Regulation Name: Electroencephalograph Regulatory Class: II Product Code: OLW, OMC, OLT, ORT, DSI Dated (Date on orig SE 1tr): September 3, 2008 Received (Date on orig SE ltr): October 14, 2008
Dear Mr. Oren:
This letter corrects our substantially equivalent letter of December 16, 2008.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{13}------------------------------------------------
Page 2 - Mr. Oren
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours.
Kesia Alexander
for
Malvina B. Evdelman, M.D. Director Division of Ophthalmic. Neurological. and Ear. Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{14}------------------------------------------------
Food and Drug Administration Traditional 510(k) submission for VitaLogik
BIS - Indication for use
The Mennen Medical VitaLogik BIS interface
is intended for use under the direct supervision of a licensed healthcare practitioner or by personnel trained in its proper use. It is intended for use on adult and pediatric patients within a hospital or medical facility providing patient care to monitor the state of the brain by data acquisition of EBG signals.
The BIS Index, a processed parameter may be used as an aid in monitoring the effects of occtain anesthetic agents. Use of BIS monitoring to help guide anesthetic administration may be associated with the reduction of the incidence of awareness with recall in adults during general anesthesia and sedation.
-
- The Bispectral Index is a complex technology, intended for use only as an adjunct to clinical judgment and training.
- & In addition, the clinical utility, risk/benefit, and application of this device have not undergone full evaluation in the pediatric population.
*The Intended Use of the VitaLogik monitor as indicated above is same as the Indications For Use.
Prescription Use YES (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use _ NO (21 CFR 801 Subpert C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEED BO
f Device Evaluation (ODE) Concl
Division of General, Restorative,
d Neurological
Page 2 of 2
§ 882.1400 Electroencephalograph.
(a)
Identification. An electroencephalograph is a device used to measure and record the electrical activity of the patient's brain obtained by placing two or more electrodes on the head.(b)
Classification. Class II (performance standards).